Is Autologous Fecal Microbiota Transfer after Exclusive Enteral Nutrition in Pediatric Crohn’s Disease Patients Rational and Feasible? Data from a Feasibility Test
Nutrients · 2023
DOI: 10.3390/nu15071742 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nutrients, 2023. Verfasst von Hannes Hoelz und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Dr. von Hauner Children's Hospital, University Hospital, LMU Munich, 80337 Munich, Germany. Hauptthemen laut MEDLINE: Enteral Nutrition, Fecal Microbiota Transplantation. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 86 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, Leona M. and Harry B. Helmsley Charitable Trust.
Abstract (Originalsprache)
Background
Exclusive enteral nutrition (EEN) is a highly effective therapy for remission induction in pediatric Crohn’s disease (CD), but relapse rates after return to a regular diet are high. Autologous fecal microbiota transfer (FMT) using stool collected during EEN-induced clinical remission might represent a novel approach to maintaining the benefits of EEN.
Methods
Pediatric CD patients provided fecal material at home, which was shipped at 4 °C to an FMT laboratory for FMT capsule generation and extensive pathogen safety screening. The microbial community composition of samples taken before and after shipment and after encapsulation was characterized using 16S rRNA amplicon sequencing.
Results
Seven pediatric patients provided fecal material for nine test runs after at least three weeks of nutritional therapy. FMT capsules were successfully generated in 6/8 deliveries, but stool weight and consistency varied widely. Transport and processing of fecal material into FMT capsules did not fundamentally change microbial composition, but microbial richness was
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, Dr. von Hauner Children's Hospital, University Hospital, LMU Munich, 80337 Munich, Germany.
- Clinical Microbiome Research Group, Department of Internal Medicine I, University Hospital of Cologne, 50931 Cologne, Germany.
- Institute for Microbiology and Hygiene, University Hospital Regensburg, 93053 Regensburg, Germany.
- Chair of Nutrition and Immunology, Technical University Munich, 85354 Freising-Weihenstephan, Germany.
- ZIEL-Institute for Food and Health, Technical University Munich, 85354 Freising-Weihenstephan, Germany.
- Section of Infectious Diseases, Department of Internal Medicine II, University Hospital Frankfurt, Goethe University Frankfurt, 60596 Frankfurt am Main, Germany.
ORCID-Profile: Hannes Hoelz, Anastasia Tsakmaklis, Andreas Hiergeist, Deborah Häcker, Amira Metwaly, Klaus Neuhaus, Tobias Schwerd
Förderung
- Deutsche Forschungsgemeinschaft
- Leona M. and Harry B. Helmsley Charitable Trust
Zitieren
APA
Hoelz, H., Heetmeyer, J., Tsakmaklis, A., Hiergeist, A., Siebert, K., De Zen, F., Häcker, D., Metwaly, A., Neuhaus, K., Gessner, A., Vehreschild, M. J. G. T., Haller, D., & Schwerd, T. (2023). Is Autologous Fecal Microbiota Transfer after Exclusive Enteral Nutrition in Pediatric Crohn’s Disease Patients Rational and Feasible? Data from a Feasibility Test. Nutrients. https://doi.org/10.3390/nu15071742
Vancouver
Hoelz H, Heetmeyer J, Tsakmaklis A, Hiergeist A, Siebert K, De Zen F, et al. Is Autologous Fecal Microbiota Transfer after Exclusive Enteral Nutrition in Pediatric Crohn’s Disease Patients Rational and Feasible? Data from a Feasibility Test. Nutrients. 2023. doi:10.3390/nu15071742
BibTeX
@article{Hoelz2023,
author = {Hoelz, Hannes and Heetmeyer, Jeannine and Tsakmaklis, Anastasia and Hiergeist, Andreas and Siebert, Kolja and De Zen, Federica and Häcker, Deborah and Metwaly, Amira and Neuhaus, Klaus and Gessner, André and Vehreschild, Maria J G T and Haller, Dirk and Schwerd, Tobias},
title = {Is Autologous Fecal Microbiota Transfer after Exclusive Enteral Nutrition in Pediatric Crohn’s Disease Patients Rational and Feasible? Data from a Feasibility Test},
journal = {Nutrients},
year = {2023},
doi = {10.3390/nu15071742}
}
EUVIMED